Vanguard Portfolio Management
BMY icon

Vanguard Portfolio Management’s Bristol-Myers Squibb BMY Stock Holding History

Vanguard Portfolio Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7B Buy
46,873,015
+642,860
+1% +$36.9M 0.12% 160
2026
Q1 		$2.8B Buy
+46,230,155
New +$2.69B 0.15% 126

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Portfolio Management's BMY Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q2 2026, buying an estimated $36.9M and bringing the position to 46,873,015 shares worth $2.7B. The position accounts for 0.12% of the portfolio, ranked #160.

Vanguard Portfolio Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.8B in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Vanguard Portfolio Management held 46,873,015 shares of Bristol-Myers Squibb worth $2.7B as of Q2 2026.
  • Vanguard Portfolio Management bought 642,860 Bristol-Myers Squibb shares in Q2 2026, an estimated $36.9M.
  • Bristol-Myers Squibb made up 0.12% of Vanguard Portfolio Management's portfolio in Q2 2026, its #160 holding.
  • Vanguard Portfolio Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Bristol-Myers Squibb position peaked at $2.8B in Q1 2026.
  • 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.